Replies to post #395684 on Amarin Corp Plc (AMRN)

[shadolane]

Back to basics, why does Amarin management care if they are effective or not?

They are doing very well for themselves as is.

I seriously doubt if any BP has their sites on Amarin.

There are just too many negative issues IMO.

And yes, I am a very big loser on this one.

So it doesn't make me happy to come to the conclusions I've come to and making the comments that I have made.

Sorry folks, we all have the big "L" on our foreheads on this one.

[ziploc_1]

A problem for Amarin has been that Vascepa is TOO EFFECTIVE in reducing CVD for adults...An argument could be made that nearly ALL ADULTS (except those with arrythmias or bleeding tendencies) should be taking Vascepa...This would appear to very expensive to governments, which support national health care systems, especially during difficult financial periods....Of course, in the long run, cash paid out by governments for Vascepa would have to be spent in even larger amounts for hospital bills{not to mention those countrymen, who would die from avoidable CVD)

The logical solution to this conundrum is for such a safe and effective drug as Vascepa to be marketed to as large population as possible for as low a price as possible...In order to accomplish this, Amarin should....

-Put Vascepa in the hands of a large Pharma with multinational marketing abilities, that would...
-Market an authorized generic Vascepa in the U.S.
-Keep the price of Vascepa low worldwide
-Start to investigate sources of supply of API from other sources than just fish(e.g.algae)